Bridgewater, NJ, November 2, 2018 – Nipro Medical Corporation announced the launch of Cellentia®-H cellulose triacetate (CTA), single-use dialyzer at the 2017 ASN Kidney Week Conference. The Cellentia®-H is the newest addition to Nipro’s growing line of high performance dialyzers. The Cellentia®-H dialyzer is indicated for all hemodialysis patients, especially those where conservative therapy is.. read more →

Bridgewater, New Jersey – April 22, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the SafeTouch Safety Needle, featuring an easy to use anti-needlestick safety design. The SafeTouch Safety Needle is the newest addition to Nipro’s portfolio of Medical-Surgical device offerings. “Nipro has been providing quality needles for over.. read more →

Bridgewater, New Jersey – February 18, 2016: Nipro North America, a division of Nipro Medical Corporation, announced the launch of the AQUALiner II 0.035” second generation hydrophilic, super-elastic Nitinol guidewire. The guidewire enables the operator to navigate through complex lesions and deliver interventional devices such as balloons and stents. The reengineered AQUALiner II is the.. read more →

Bridgewater, New Jersey – July 10, 2015: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation, announced at the 2015 AVMA Convention, the launch of Nipro VSmart products dedicated to the veterinary market. Nipro is a leading manufacturer of medical devices with a good presence in the pet.. read more →

Global leadership in design and manufacturing targets better dialysis patient outcomes for U.S. market Bridgewater, New Jersey – November 11, 2014: Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing, announced at Kidney Week 2014, the launch of the.. read more →